![]() |
|
|


University of New Mexico Health Sciences Center, Albuquerque, NM;
* University of Minnesota, Minneapolis, MN;
Serono Laboratories, Norwell, MA;
** Harlem Hospital Center, New York, NY; and
Washington Regional AIDS Program, Annandale, VA
3To whom correspondence should be addressed. E-mail: bwilliams{at}salud.unm.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: protein body composition human immunodeficiency virus
Wasting has been a common feature of the human immunodeficiency virus (HIV) epidemic since its appearance in the early 1980sand is associatedwith increased morbidity and mortality (1 ,2 ). Although all body compartments are affected, (3 ,4 ) loss of body cell mass (BCM) is strongly associated with disease progression and predicts mortality (2 ,5 ).
Because protein is the principal component of BCM, fluctuations in its metabolism may contribute to clinically important wasting. Studies of whole-body protein turnover in HIV patients suggest that it is correlated with BCM (6 ) and protein intake (7 ). This is consistent with findings reported from studies in animals (8 ), elderly women (9 11 ) and burn patients (12 ). A previous cross-sectional study in HIV-infected patients found that, in fact, protein intake was highly correlated with lean body mass (13 ).
In animals and in normal, untrained male volunteers, protein intake in the absence of resistance exercise does not result in enhanced protein synthesis in skeletal muscle (14 ,15 ). It is not known, however, whether this is the case in malnourished or chronically ill individuals, such as those with HIV disease, because relevant studies have yet to be conducted.
The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) conducted a randomized, controlled trial comparing the ability of three oral dietary regimens to maintain or increase body weight and BCM in HIV-infected patients with stable (nondecreasing) weight and CD4+ cell counts <200 cells/mm3 (16 ). Baseline data collected afford the opportunity to ask whether protein intake is independently associated with BCM in clinically weight-stable HIV-infected patients.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Baseline data from CPCRA 039, a multicenter, randomized, open-label nutritional supplementation study conducted among HIV-infected patients between July 31, 1996 and November 30, 1997 were analyzed for this paper. Entry criteria and study procedures are described elsewhere (16 ). Of the 536 randomized patients, 467 were men with baseline dietary recall data available and provide the basis of this paper. The number of women participating in the trial was insufficient to draw statistically valid conclusions concerning the question posed here.
Body composition.
Height and weight were measured following a standard procedure. Body composition was measured according to a written protocol using a single-frequency bioelectrical impedance analysis (BIA)-101Q analyzer (RJL Systems, Clinton Township, MI). Formulas for computing BCM, total body fat (TBF) and extracellular mass (ECM) were provided by the manufacturer as published (17 ).
Dietary recall.
Macronutrient intake was assessed from a single 24-h dietary recall using the Minnesota Nutrition Data System NDS-93, Food Database version 11A, Nutrient Database version 26, developed by the Nutrition Coordinating Center at the University of Minnesota, Minneapolis, MN (18 ,19 ).
Muscle-building activity (MBA).
Participation in MBA during the month before enrollment was assessed by a specially prepared questionnaire in which patients were asked to rate their level of MBA at one of seven levels: no regular activity (2 levels), some activity not involving a training program (2 levels) or regular participation in a weight-training program (3 levels). The validity of this questionnaire for this population was confirmed in a pilot study conducted in three CPCRA units before its use in the nutritional supplementation study (20 ).
Statistical Analysis.
Stepwise multiple regression with backward elimination was used to determine which variables were associated in the presence of the other variables in the regression model. The starting list of variables was as follows: 1) age (y); 2) weight (kg); 3) height (m); 4) height; 5) three variables for race/ethnicity categories; 6) prior injection drug use (IDU); 7) MBA (7 levels); 8) CD4 cell count; 9) number of prior AIDS-related diagnoses (ARD) events; 10) treatment with protease inhibitor at baseline, 11) total protein intake (g/d); 12) animal protein intake (g/d); 13) vegetable protein intake (g/d); 14) carbohydrate intake (g/d); and 15) fat intake (g/d). A variable remained in the model if its associated significance level in the final model was <0.05.
| RESULTS |
|---|
|
|
|---|
Among the 467 HIV-infected males included in the study, the mean age was 40 y and there was a diverse ethnic representation. The cohort exhibited relatively advanced HIV disease with a mean CD4+ cell count of 104 cells/mm3 and 54.8% having had at least one ARD. Body composition and macronutrient intake variables included a mean BCM of 28.2 kg and mean daily energy, protein and carbohydrate intakes of 13.97 MJ, 117.9 g and 432.4 g, respectively. Other characteristics of the cohort are listed in Table 1 .
|
Eighty-four (18%) participants reported regularly participating in a weight training program. One hundred thirty-five (28%) reported regularly performing some strength-building exercises, whereas 248 (53%) reported not regularly participating in any program.
Backward stepwise regression analysis of variables associated with body composition parameters.
For BCM and ECM, the backward stepwise regression resulted in the selection of weight, height, MBA, age, African American, number of ARD events, total daily protein intake and daily carbohydrate intake in the final models (Table 2 ). When "total protein" (g) was replaced by two terms, i.e., "animal protein" (g) and "vegetable protein" (g), "animal protein" was retained in the model and "vegetable protein" was the last eliminated. When "animal protein" was expressed as a percentage of total protein intake, it was the first variable eliminated in the backward elimination process. We therefore concluded that animal and vegetable protein intakes were nearly equivalent in their associations with BCM. Given this equivalence, total protein (g) was used in the present analysis.
|
| DISCUSSION |
|---|
|
|
|---|
The significant, positive association between protein intake and BCM independent of MBA observed here most likely represents a clinically meaningful relationship. In asymptomatic HIV-infected patients, protein intake is greater than that of uninfected individuals (21 ). In chronic HIV infection, increased whole-body protein turnover may require greater intake to provide adequate substrate to maintain BCM homeostasis (6 ), possibly to compensate for a subclinical protein-wasting enteropathy, whereas MBA is required for anabolism beyond baseline. Because a controlled, biochemical analysis of protein turnover was not conducted in this study, its relationship to the association between protein intake and BCM observed here cannot be determined.
In this study, the sources of dietary protein contributed equally to the observed association of protein intake with BCM. Whether this would hold true in a prospective trial randomized on the basis of protein source is not known. Assuming a similar daily protein intake and availability of a comprehensive complement of amino acids, however, there is no reason to assume the superiority of one component over the other with regard to an association with BCM.
Carbohydrate intake was negatively associated with BCM. The reasons for this are unclear although it is possible that patients whose diets include a greater proportion of carbohydrates consume a proportionately lower amount of protein. This would be consistent with the main finding that greater protein intake is positively associated with BCM.
CD4 cell count was not associated with any body composition variables in this cohort. This most likely is explained by the fact that all patients were asymptomatic and weight stable at study entry. In this context, CD4 cell counts may offer only a long-term prognosis concerning disease progression, which does not reliably reflect body composition in the absence of decreased intake or active opportunistic disease.
In the present study, a negative correlation between BCM and the number of prior ARD events was observed, whereas no association between ARD and TBF was noted. Whether this is because fat repletion occurs preferentially after the resolution of opportunistic infections, whereas BCM repletion occurs more slowly or incompletely, was not evaluated in this study, although this mechanism is supported by others (22 ,23 ). Because it is not known whether a "threshold of benefit" of dietary protein intake exists, a prospective protein supplementation trial comparing symptomatic and asymptomatic populations may be warranted.
The use of highly active antiretroviral regimens (HAART), particularly those including protease inhibitors, has been associated with significant changes in body composition (24 ,25 ). In this study, all patients were following antiretroviral regimens, 74% of which included a protease inhibitor. No differences in BCM or protein intake between those taking protease inhibitors and those not taking them were observed. Because the duration, content and virologic efficacy of protease inhibitorcontaining HAART regimens were not controlled in this study, it is not possible to identify a relationship with BCM.
African-American ethnicity was independently associated with BCM in this study. None of the measures considered here, including MBA and protein intake, altered this association when controlling for age, weight and height. This cannot be explained on the basis of the data measured here and may simply reflect genetic differences. It is unlikely that it is an artifact of BIA measurement because the equations used are not affected by race (17 ). Further research is required to determine whether other factors are present and could be useful in specifying therapeutic recommendations for this group.
When the data were analyzed in a stepwise backward elimination regression, no association between a history of IDU and any variable associated with body mass was found. In particular, a history of IDU was not independently associated with BCM (P = 0.72). Previous studies of body composition among IDU have been inconclusive but in general are consistent with this finding (26 28 ).
Several limitations of this study point to the need for additional clinical trials. The utility of the 24-h dietary recall in accurately characterizing nutritional intake has been questioned (29 ). The accuracy of self-reporting and short duration of recall may not reliably capture longer-term dietary trends. Prospective food logs, 72-h recalls or even direct observation may improve the accuracy and precision of macronutrient intake estimates (30 ). Although it is reassuring that the mean protein intake observed here is consistent with previous estimates of daily requirements in HIV patients (21 ,31 ), a more intensive, long-term prospective evaluation of an outpatient population would be helpful.
An additional limitation of this study was that only one method was available to assess BCM, i.e., single-frequency BIA, a method that has been validated for HIV patients using total body potassium scanning and isotopic dilution techniques as criterion methods (22 ). Although this validation study included HIV patients studied before the widespread use of HAART, single-frequency BIA has been widely used in recent clinical studies in patients receiving HAART (32 ,33 ) and is common in clinical practice today (34 ). The method therefore has external validity for studies such as this one.
The results reported here for men, although suggestive, cannot be validly extrapolated to women. Body composition changes associated with the variables tested here should be explored in HIV-infected women in future trials.
As a cross-sectional study, the associations identified here suggest, but do not prove, an independent relationship between protein intake and BCM in HIV-infected men. Confounding variables not identified here, particularly those associated with improved viral suppression and disease prophylaxis, may be present. A longitudinal, randomized, prospective trial examining the role of protein intake in maintaining BCM in weight-stable HIV-infected patients conducted within the context of careful scrutiny of antiretroviral and opportunistic infection prophylactic therapy is required to confirm these results.
Although this study supports an independent association between protein intake and BCM, we cannot conclude from the present data that increasing protein intake will lead to clinically important increases in BCM. In the non-HIVinfected elderly, age-related skeletal muscle mass loss is not prevented by either protein intake or exercise above a minimum level (35 ). A prospective comparison evaluating dietary intake and MBA in asymptomatic HIV-infected patients and HIV-negative controls would be helpful in determining whether protein intake is more important in maintaining BCM in chronic HIV disease than in an uninfected state.
| FOOTNOTES |
|---|
2 This study was supported by funding from the National Institute of Allergy and Infectious Diseases (NIAID) through the Terry Beirn Community Programs for Clinical Research on AIDS. ![]()
4 AA, African-American; AIDS, acquired immunodeficiency syndrome; ARD, AIDS-related diagnosis(es); BCM, body cell mass; BIA, bioelectrical impedance analysis; BMI, body mass index; CPCRA, Terry Beirn Community Programs for Clinical Research on AIDS; ECM, extracellular mass; HAART, highly active antiretroviral therapy; HIV, human immunodeficiency virus; IDU, injection drug use(r); MBA, muscle-building activity; TBF, total body fat. ![]()
Manuscript received 16 October 2002. Initial review completed 18 November 2002. Revision accepted 17 January 2003.
| LITERATURE CITED |
|---|
|
|
|---|
1. Wheeler, D. A., Gibert, C., Launer, C. A., Muurahainen, N., Elion, R. A., Abrams, D. I. & Bartsch, G. (1998) Weight loss as a predictor of survival and disease progression in HIV infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:80-85.[Medline]
2. Suttman, U., Ockenga, J., Selberg, O., Hoogestraat, L., Deicher, H. & Muller, M. J. (1995) Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8:239-246.[Medline]
3. Mulligan, K., Tai, V. W. & Schambelan, M. (1997) Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15:43-48.[Medline]
4. Paton, N.I.J., Macallan, D. C., Jebb, S. A., Noble, C., Baldwin, C., Pazianas, M. & Griffin, G. E. (1997) Longitudinal changes in body composition measured with a variety of methods in patients in AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:119-127.[Medline]
5. Kotler, D. P., Wang, J. & Pierson, R. N. (1985) Body composition studies in patients with the acquired immunodeficiency syndrome. Am. J. Clin. Nutr. 42:1255-1265.
6. Selberg, O., Suttman, U., Melzer, A., Deicher, H., Muller, M.-J., Henkel, E. & McMillan, D. C. (1995) Effect of increased protein intake and nutritional status on whole-body protein metabolism in AIDS patients with weight loss. Metabolism 44:1159-1165.[Medline]
7. Macallan, D. C., McNurlan, M. A., Milne, E., Calder, A. G., Garlick, P. J. & Griffin, G. E. (1995) Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. Am. J. Clin. Nutr. 61:818-826.
8. Wykes, L. J., Fiorotto, M., Burrin, D. G., Del Rosario, M., Frazer, M. E., Pond, W. G. & Jahoor, F. (1996) Chronic low protein intake reduces tissue protein synthesis in a pig model of protein malnutrition. J. Nutr. 126:1481-1488.
9. Castaneda, C., Dolnikowski, G. G., Dallal, G. E., Evans, W. J. & Crim, M. C. (1995) Protein turnover and energy metabolism of elderly women fed a low-protein diet. Am. J. Clin. Nutr. 62:40-48.
10. Baumgartner, R. N., Koehler, K. M., Romero, L. & Garry, P. J. (1996) Serum albumin is associated with skeletal muscle in elderly men and women. Am. J. Clin. Nutr. 64:552-558.
11. de Groot, L.C.P.G.M. & van Staveren, W. A. (1996) Low-protein intakes and protein turnover in elderly women. Nutr. Rev. 54:58-65.[Medline]
12. Demling, R. H. & DeSanti, L. (1998) Increased protein intake during the recovery phase after severe burns increases body weight gain and muscle function. J. Burn Care Rehabil. 19:161-168.[Medline]
13. DiFranco, M. G., Woods, M., Spiegelman, D., Knox, T. & Gorbach, S. (1996) Nutritional correlates with CD4 counts in HIV-infected individuals. XI International AIDS Conference, July, 1996 1996 Vancouver, BC. (abs.).
14. Taillandier, D., Guezennec, C.-Y., Patureau-Mirand, P., Bigard, X., Arnal, M. & Attaix, D. (1996) A high protein diet does not improve protein synthesis in the nonweight-bearing rat tibialis anterior muscle. J. Nutr. 126:266-272.
15. Biolo, G., Tipton, K. D., Klein, S. & Wolfe, R. R. (1997) An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am. J. Physiol. 273:E122-E129.
16. Gibert, C. L., Wheeler, D. A., Collins, G., Madans, M., Muurahainen, N., Raghavan, S. S. & Bartsch, G. (1999) Randomized, controlled trial of caloric supplements in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS.. J. Acquir. Immune Defic. Syndr. 22:253-259.
17. Kotler, D. P., Burastero, S., Wang, J. & Pierson, R. N. (1996) Prediction of body cell mass, fat free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am. J. Clin. Nutr. 64:489S-497S.
18. Dennis, B., Ernst, N., Hjortland, M., Tillotson, J. & Grambsch, V. (1980) The NHLBI nutrition data system. J. Am. Diet. Assoc. 7:641-647.
19. Schakel, S., Sievert, Y. & Buzzard, I. (1988) Sources of data for developing and maintaining a nutrient database. J. Am. Diet. Assoc. 88:1268-1271.[Medline]
20. Myers, M. J., Walker, A. J., Collins, G., Bartsch, G., Launer, C. & Williams, B. (1998) Muscle building activity versus physical activity questionnaire as a predictor of body composition. American College of Sports Medicine 45th Annual Meeting, May, 1998 1998 Orlando, FL.
21. McCorkindale, C., Dybevik, K., Coulston, A. M. & Sucher, K. P. (1990) Nutritional status of HIV-infected patients during the early disease stages. J. Am. Diet. Assoc. 90:1236-1241.[Medline]
22. Kotler, D. P., Tierney, A. R., Wang, J. & Pierson, R. N. (1989) Magnitude of body-cell-mass depletion and the timing of death in AIDS. Am. J. Clin. Nutr. 50:444-447.
23. Macallan, D. C., Noble, C., Baldwin, C., Foskett, M., McManus, T. & Griffin, G. E. (1993) Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am. J. Clin. Nutr. 58:417-424.
24. Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. & Cooper, D. (1998) A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51-F58.[Medline]
25. Lo, J., Mulligan, K., Tai, V., Algren, H. & Schambelan, M. (1998) "Buffalo hump" in men with HIV-1 infection. Lancet 351:867-870.[Medline]
26. Gomez-Sirvent, J. L., Santolaria-Fernandez, F. J., Gonzalez-Reimers, C. E., Batista-Lopez, J. N., Jorge-Hernandez, J. A., Rodriguez-Moreno, F., Martinez-Riera, A. & Hernandez-Garcia, M. T. (1993) Nutritional assessment of drug addicts.Relation with HIV infection in early stages. Clin. Nutr. 12:75-80.
27. Sorkin, J. D., Bolton, P. A., Greenblatt, J., Sithisarankul, P., Vlahov, D. & Graham, N. M. H. (1995) Age, gender, and other predictors of the wasting syndrome among HIV-1-infected injecting drug users. Epidemiology 6:172-177.[Medline]
28. Marmor, M., Titus, S., Harrison, C., Cord-Cruz, E. A., Shore, R. E., Vogler, M., Krasinski, K., Mildran, D. & Jarlais, D.C.D. (1996) Weight loss associated with HIV seroconversion among injection-drug users. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12:514-518.[Medline]
29. Medlin, C. & Skinner, J. (1988) Individual dietary intake methodology: 50-year review of progress. J. Am. Diet. Assoc. 88:1250-1257.[Medline]
30. Jeor, S. S., Guthrie, H. & Jones, M. (1983) Variability in nutrient intake in a 28-day period. J. Am. Diet. Assoc. 83:155-159.[Medline]
31. Dworkin, B. M., Wormser, G. P., Axelrod, F., Pierre, N., Schwarz, E., Schwarz, E. & Seaton, T. (1990) Dietary intake in patients with acquired immunodeficiency syndrome (AIDS), patients with AIDS-related complex, and serologically positive human immunodeficiency virus patients: correlations with nutritional status. J. Parenter. Enteral Nutr. 14:605-609.[Abstract]
32. Mulligan, K., Zackin, R., Clark, R., Sattler, F., Santana, J., Delvers, T. & Currier, J. (2001) Nandrolone decanoate increases weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. 8th Conference on Retroviruses and Opportunistic Infections 2001 Chicago, IL.
33. Schambelan, M., Zackin, R., Mulligan, K., Sattler, F., Chesney, M., Stevens, M., Edwards, L., Egorin, M. J. & Von Roenn, J. H. (2001) Effect of testosterone (T) on the response to megesterol acetate (MA) in patients with HIV-associated wasting: a randomized, double-blind placebo-controlled trial (ACTG 313). 8th Conference on Retroviruses and Opportunistic Infections 2001 Chicago, IL.
34. Polsky, B., Kotler, D. & Steinhart, C. (2001) HIV-associated wasting in the HAART era: guidelines for assessment, diagnosis, and treatment. AIDS Patient Care and STDs 15:411-423.[Medline]
35. Starling, R. D., Ades, P. A. & Poehlman, E. T. (1999) Physical activity, protein intake, and appendicular skeletal muscle mass in older men. Am. J. Clin. Nutr. 70:91-96.
This article has been cited by other articles:
![]() |
P. Crenn, B. Rakotoanbinina, J.-J. Raynaud, F. Thuillier, B. Messing, and J.-C. Melchior Hyperphagia Contributes to the Normal Body Composition and Protein-Energy Balance in HIV-Infected Asymptomatic Men J. Nutr., September 1, 2004; 134(9): 2301 - 2306. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||